These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30143008)

  • 21. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds.
    Schneider RK; Puellen A; Kramann R; Raupach K; Bornemann J; Knuechel R; Pérez-Bouza A; Neuss S
    Biomaterials; 2010 Jan; 31(3):467-80. PubMed ID: 19815272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
    Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
    Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immuno-suppressive effects on T cells mediated by mesenchymal stem cells from patients with myelodysplastic syndrome].
    Liu LH; Chen H; Chen B; Sun Z; Ye LP; Shi B; Jin JG; Zhao CH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):299-304. PubMed ID: 18426653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Change of cytokine expressions on bone marrow mesenchymal stem cells in patients with bone marrow failure syndromes and its significance].
    Yang SM; Lu SF; Fei XM; Zhang JF; Shen WY; Li JY; Lu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1560-3. PubMed ID: 21176370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of CD34(-) and CD34(+) cell apoptosis and proliferation in bone marrow of patients with MDS and their impact on survival.
    Xia B; Guo Q; Zhao DD; Zhao HF; Han XP; Wang H; Wu XX; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1392-7. PubMed ID: 23257440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes.
    Klaus M; Stavroulaki E; Kastrinaki MC; Fragioudaki P; Giannikou K; Psyllaki M; Pontikoglou C; Tsoukatou D; Mamalaki C; Papadaki HA
    Stem Cells Dev; 2010 Jul; 19(7):1043-54. PubMed ID: 19788374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function.
    Sarhan D; Wang J; Sunil Arvindam U; Hallstrom C; Verneris MR; Grzywacz B; Warlick E; Blazar BR; Miller JS
    JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32045384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amniotic Mesenchymal Stromal Cells Exhibit Preferential Osteogenic and Chondrogenic Differentiation and Enhanced Matrix Production Compared With Adipose Mesenchymal Stromal Cells.
    Topoluk N; Hawkins R; Tokish J; Mercuri J
    Am J Sports Med; 2017 Sep; 45(11):2637-2646. PubMed ID: 28541092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix-bound Cyr61/CCN1 is required to retain the properties of the bone marrow mesenchymal stem cell niche but is depleted with aging.
    Marinkovic M; Dai Q; Gonzalez AO; Tran ON; Block TJ; Harris SE; Salmon AB; Yeh CK; Dean DD; Chen XD
    Matrix Biol; 2022 Aug; 111():108-132. PubMed ID: 35752272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
    Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.
    Weickert MT; Hecker JS; Buck MC; Schreck C; Rivière J; Schiemann M; Schallmoser K; Bassermann F; Strunk D; Oostendorp RAJ; Götze KS
    Sci Rep; 2021 Mar; 11(1):5944. PubMed ID: 33723276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
    Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
    Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis.
    Wenk C; Garz AK; Grath S; Huberle C; Witham D; Weickert M; Malinverni R; Niggemeyer J; Kyncl M; Hecker J; Pagel C; Mulholland CB; Müller-Thomas C; Leonhardt H; Bassermann F; Oostendorp RAJ; Metzeler KH; Buschbeck M; Götze KS
    Blood Adv; 2018 Dec; 2(23):3447-3461. PubMed ID: 30518537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of odontogenic and osteogenic genes in bone marrow mesenchymal stem cells with overexpression of mouse dentin sialophosphoprotein].
    Zhu F; Nie RR; Wu L; Liu L; Tang W; Tian WD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):290-3. PubMed ID: 18630706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
    Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
    Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes.
    Kim M; Hwang S; Park K; Kim SY; Lee YK; Lee DS
    PLoS One; 2015; 10(3):e0120602. PubMed ID: 25803272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vertebral body versus iliac crest bone marrow as a source of multipotential stromal cells: Comparison of processing techniques, tri-lineage differentiation and application on a scaffold for spine fusion.
    Fragkakis EM; El-Jawhari JJ; Dunsmuir RA; Millner PA; Rao AS; Henshaw KT; Pountos I; Jones E; Giannoudis PV
    PLoS One; 2018; 13(5):e0197969. PubMed ID: 29795650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
    Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD
    Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL
    J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.